These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9111819)

  • 41. The association of PASI scores with CRH-R1 expression in patients with psoriasis.
    Cemil BC; Canpolat F; Yilmazer D; Eskioğlu F; Alper M
    Arch Dermatol Res; 2012 Mar; 304(2):127-32. PubMed ID: 22350180
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interleukin-18 levels in the plasma of psoriatic patients correlate with the extent of skin lesions and the PASI score.
    Pietrzak A; Lecewicz-Torun B; Chodorowska G; Rolinski J
    Acta Derm Venereol; 2003; 83(4):262-5. PubMed ID: 12926796
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Methotrexate, but not narrowband ultraviolet B radiation, suppresses interleukin-33 mRNA levels in psoriatic plaques and protein levels in serum of patients with psoriasis.
    Meephansan J; Subpayasarn U; Ponnikorn S; Chakkavittumrong P; Juntongjin P; Komine M; Ohtsuki M; Poovorawan Y
    J Dermatol; 2018 Mar; 45(3):322-325. PubMed ID: 28836690
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of skin area, age and sex on corneometric determinations.
    Mussi A; Carducci M; D'Agosto G; Bonifati C; Fazio M; Ameglio F
    Skin Res Technol; 1998 May; 4(2):83-7. PubMed ID: 27332104
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Elevated serum levels of calcium-binding S100 proteins A8 and A9 reflect disease activity and abnormal differentiation of keratinocytes in psoriasis.
    Benoit S; Toksoy A; Ahlmann M; Schmidt M; Sunderkötter C; Foell D; Pasparakis M; Roth J; Goebeler M
    Br J Dermatol; 2006 Jul; 155(1):62-6. PubMed ID: 16792753
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nail dystrophies, scalp and intergluteal/perianal psoriatic lesions: risk factors for psoriatic arthritis in mild skin psoriasis?
    Patrizi A; Venturi M; Scorzoni R; Pazzaglia M; Malavolta N; Bardazzi F
    G Ital Dermatol Venereol; 2014 Apr; 149(2):177-84. PubMed ID: 24819637
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relationship between Histological and Clinical Course of Psoriasis: A Pilot Investigation by Reflectance Confocal Microscopy during Goeckerman Treatment.
    Archid R; Duerr HP; Patzelt A; Philipp S; Röwert-Huber HJ; Ulrich M; Meinke MC; Knorr F; Lademann J
    Skin Pharmacol Physiol; 2016; 29(1):47-54. PubMed ID: 26841099
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumour necrosis factor alpha (TNF-alpha)-converting enzyme (TACE) and soluble TNF-alpha receptor type 1 in psoriasis patients treated with narrowband ultraviolet B.
    Serwin AB; Sokolowska M; Chodynicka B
    Photodermatol Photoimmunol Photomed; 2007 Aug; 23(4):130-4. PubMed ID: 17598866
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IMO-8400, a toll-like receptor 7, 8, and 9 antagonist, demonstrates clinical activity in a phase 2a, randomized, placebo-controlled trial in patients with moderate-to-severe plaque psoriasis.
    Balak DM; van Doorn MB; Arbeit RD; Rijneveld R; Klaassen E; Sullivan T; Brevard J; Thio HB; Prens EP; Burggraaf J; Rissmann R
    Clin Immunol; 2017 Jan; 174():63-72. PubMed ID: 27876460
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum level of receptor activator of nuclear factor kappa-B ligand in patients with psoriasis.
    Amin TE; ElFar NN; Ghaly NR; Hekal MM; Hassan AM; Elsaadany HM
    Int J Dermatol; 2016 May; 55(5):e227-33. PubMed ID: 26712216
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics.
    Papoutsaki M; Chimenti MS; Costanzo A; Talamonti M; Zangrilli A; Giunta A; Bianchi L; Chimenti S
    J Am Acad Dermatol; 2007 Aug; 57(2):269-75. PubMed ID: 17574299
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neuropeptides and their receptors in psoriatic skin in relation to pruritus.
    Chang SE; Han SS; Jung HJ; Choi JH
    Br J Dermatol; 2007 Jun; 156(6):1272-7. PubMed ID: 17535226
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interleukin-1 receptor antagonist, soluble tumor necrosis factor-alpha receptor type I and II, and soluble E-selectin serum levels in multiple sclerosis patients receiving weekly intramuscular injections of interferon-beta1a.
    Perini P; Tiberio M; Sivieri S; Facchinetti A; Biasi G; Gallo P
    Eur Cytokine Netw; 2000 Mar; 11(1):81-6. PubMed ID: 10705303
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relationship between clinical response to therapy and health-related quality of life outcomes in patients with moderate to severe plaque psoriasis.
    Revicki DA; Willian MK; Menter A; Saurat JH; Harnam N; Kaul M
    Dermatology; 2008; 216(3):260-70. PubMed ID: 18187944
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum fatty acid profile in psoriasis and its comorbidity.
    Myśliwiec H; Baran A; Harasim-Symbor E; Myśliwiec P; Milewska AJ; Chabowski A; Flisiak I
    Arch Dermatol Res; 2017 Jul; 309(5):371-380. PubMed ID: 28585093
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Elevation of serum squamous cell carcinoma antigen 2 in patients with psoriasis: associations with disease severity and response to the treatment.
    Watanabe Y; Yamaguchi Y; Komitsu N; Ohta S; Azuma Y; Izuhara K; Aihara M
    Br J Dermatol; 2016 Jun; 174(6):1327-36. PubMed ID: 26822223
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Downregulation of SMAD2, 4 and 6 mRNA and TGFbeta receptor I mRNA in lesional and non-lesional psoriatic skin.
    Yu H; Mrowietz U; Seifert O
    Acta Derm Venereol; 2009; 89(4):351-6. PubMed ID: 19688145
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum lipid profile in psoriatic patients: correlation between vascular adhesion protein 1 and lipoprotein (a).
    Nemati H; Khodarahmi R; Rahmani A; Ebrahimi A; Amani M; Eftekhari K
    Cell Biochem Funct; 2013 Jan; 31(1):36-40. PubMed ID: 22753196
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum concentrations of interleukin-2 and tumour necrosis factor-α under cyclosporine versus acitretin treatment in plaque-type psoriasis.
    Akçali C; Guven EH; Kirtak N; Inaloz HS; Ozgoztasi O; Guvenc U
    J Int Med Res; 2014 Oct; 42(5):1118-22. PubMed ID: 25143337
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Elevated Local and Serum CX3CL1(Fractalkine) Expression and Its Association with Disease Severity in Patients with Psoriasis.
    Congjun J; Yanmei Z; Huiling J; Zhen Y; Shuo L
    Ann Clin Lab Sci; 2015; 45(5):556-61. PubMed ID: 26586708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.